[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368771-105":59,"doc-detail-368771-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pibf1-expression-and-survival-outcome-in-tnbc-and-non-tnbc-breast-cancer-patients-with-lymph-node-metastasis-undergoing-chemotherapy","PIBF1 expression and survival outcome in TNBC and Non-TNBC breast cancer patients with lymph node metastasis undergoing chemotherapy","","Progesterone-induced blocking factor 1 (PIBF1), linked to pregnancy immunity and tumor evasion, is investigated in breast cancer for its expression patterns, prognostic value, and relationship with chemotherapy response. A cohort of 231 high-risk TNBC patients with lymph node metastasis treated with surgery and taxane-based adjuvant chemotherapy was compared with 238 matched non-TNBC patients. PIBF1 protein was assessed by immunohistochemistry and survival analyzed using Kaplan–Meier overall survival. In vitro studies in breast cancer cell lines evaluated chemosensitivity and effects of PIBF1 knockdown, supporting PIBF1 as a potential predictive marker guiding therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pibf1-expression-and-survival-outcome-in-tnbc-and-non-tnbc-breast-cancer-patients-with-lymph-node-metastasis-undergoing-chemotherapy/368771/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pibf1-expression-and-survival-outcome-in-tnbc-and-non-tnbc-breast-cancer-patients-with-lymph-node-metastasis-undergoing-chemotherapy/368771.png","ImageObject",300,407,{"name":92,"@type":93},"Mabel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does PIBF1 play in tumor immune evasion and why is it studied in breast cancer?","Question",{"text":112,"@type":113},"PIBF1 is associated with pregnancy-induced immunity and tumor evasion of maternal immunity. Limited prior work on PIBF1 in breast cancer motivates evaluating its clinical outcomes and therapy response potential.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients grouped to compare TNBC and non-TNBC outcomes?",{"text":117,"@type":113},"The study collected samples from 231 high-risk TNBC patients treated with surgery and taxane-based adjuvant chemotherapy, then selected 238 matched non-TNBC patients for comparison.",{"name":119,"@type":110,"acceptedAnswer":120},"How does PIBF1 expression relate to prognosis and chemotherapy sensitivity?",{"text":121,"@type":113},"Higher PIBF1 expression is associated with a better prognosis, particularly in the non-TNBC cohort. In vitro, PIBF1 expression correlates with paclitaxel sensitivity, and resistance to treatment can be observed after PIBF1 knockdown.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368771,1790288745,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPIBF1 expression and survival outcome inTNBC and Non-TNBC breast cancer patients with lymph node metastasis who undertaken chemotherapy  \nEunju Shin1, Jewon Ryu2, Tae-Kyung Yoo1, Sae Byul Lee1, Jisun Kim1, Il Yong Chung1, Beom Seok Ko1, Hee Jeong Kim1, Jong Won Lee1, Jun Hyeong Lee3, Kyunggon Kim4, Sang-wook Lee5􀀍 & Byung Ho Son1􀀍  \nProgesterone-induced blocking factor 1 (PIBF1) is linked to pregnancy-induced immunity and tumor evasion of maternal immunity. PIBF1 is overexpressed in several cancers, including breast, cervical, and lymphoma. However, limited research is available on the role of PIBF1 in breast cancer and its clinical outcomes. Therefore, we investigated the relationship between PIBF1 expression, prognosis, and its impact on chemotherapy response. Samples from 231 patients with high-risk triple-negative breast cancer (TNBC) who underwent surgery between 2008 and 2013 with lymph node metastasis and underwent taxane-based adjuvant chemotherapy were collected. Additionally, 238 non-TNBC patients matched toTNBC patients were selected. Immunohistochemical detection of the PIBF1 protein in tissues was conducted using a cut-off value of 3 (intensity plus proportion) . Kaplan–Meier survival analysis assessed the probability of overall survival (OS). Using the clonogenic unit assay and knockdown methodologies in breast cancer cell lines, we examined the correlation between PIF1 expression and chemosensitivity. In a study of 469 patients with breast cancer, non-TNBC (n = 238) and TNBC (n = 231), those with PIBF1 expression manifested a lower histologic grade (p \u003C 0.001), reduced p53 (p \u003C 0.001) and decreased Ki-67 (p \u003C 0.001) compared with their non-expressing counterparts. A significant difference in OS for patients with PIBF1 was observed, with non-TNBC patients showing superior outcomes. PIBF1 expression showed a relation with a better prognosis, and the statistical significance was borderline (hazard ratio = 0.44, 95% confidence interval = 0.18–1.11, p = 0.082) . A correlation between PIBF1 expression in breast cancer cell lines (BT549, HCC70, BT20, and HS578T) and their sensitivity to paclitaxel was shown in vitro, with certain cell lines showing significant viability reductions and also resisting the treatment after PIBF1 knockdown. We observed a correlation between PIBF1 expression and improved prognosis in breast cancer patients with nodal metastasis undergo taxane-based chemotherapy, particularly in the non-TNBC cohort. We discerned a relationship between PIBF1 and chemosensitivity in our in vitro studies. These findings suggest the potential usefulness of PIBF1 as a predictive marker for guiding therapeutic approaches.  \nKeywords Breast cancer, Progesterone-induced blocking factor, Chemotherapy, Response, In vitro  \nAbbreviations  \nATCC American type culture collection CI Confidence interval  \nDFS Diseade-free survival  \n1Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. 2Department of Convergence Medicine, Asan Medical Center, Seoul, Korea. 3La Sierra University, 4500 Riverwalk Pkwy, Riverside, CA, USA. 4Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. 5Department of Radiation Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. 􀀍 email: [lsw@amc.seoul.kr](lsw@amc.seoul.kr); [brdrson@korea.com](brdrson@korea.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nER Estrogen receptor  \nG Grade  \nHER2 Human epidermal growth factor receptor 2  \nHR Hazard ratio  \nOS Overall survival  \nPGR Progesterone receptor  \nPIBF1 Progesterone-induced blocking factor 1  \nSD Standard deviation  \nSNB Sentinal node biopsy  \nTNBC Triple-negative breast cancer  \nBreast cancer remains a global health concern, impacting many individuals each year. Its complex a","cbCain5rwQrCclM6","https://ap.wps.com/l/cbCain5rwQrCclM6","pdf",2881578,15,"English","# Background\n## Need for tumor markers and risk stratification\n# Methods and Cohorts\n## Patient selection and treatment\n## PIBF1 detection and survival analysis\n# Results\n## Clinical prognostic associations\n## In vitro chemosensitivity and knockdown findings\n# Implications\n## Predictive value for therapeutic guidance","[{\"question\":\"What role does PIBF1 play in tumor immune evasion and why is it studied in breast cancer?\",\"answer\":\"PIBF1 is associated with pregnancy-induced immunity and tumor evasion of maternal immunity. Limited prior work on PIBF1 in breast cancer motivates evaluating its clinical outcomes and therapy response potential.\"},{\"question\":\"How were patients grouped to compare TNBC and non-TNBC outcomes?\",\"answer\":\"The study collected samples from 231 high-risk TNBC patients treated with surgery and taxane-based adjuvant chemotherapy, then selected 238 matched non-TNBC patients for comparison.\"},{\"question\":\"How does PIBF1 expression relate to prognosis and chemotherapy sensitivity?\",\"answer\":\"Higher PIBF1 expression is associated with a better prognosis, particularly in the non-TNBC cohort. In vitro, PIBF1 expression correlates with paclitaxel sensitivity, and resistance to treatment can be observed after PIBF1 knockdown.\"}]","PIBF1 expression and survival outcome in TNBC and Non-TNBC breast cancer patients with lymph node metastasis undergoing chemotherapy | PDF",1790178466,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9734655e07216177c59b89d9e2675b3.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2090289f91eed9053c95f6e7a29e507e.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10409c3921f5297984d7bb7a6310b5ff.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8229c36dee62a40d66cc535375d6d56.webp",980,1287]